for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Cosmo Pharmaceuticals' Rifamycin SV MMX Gets Marketing Authorization In Italy

July 8 (Reuters) - COSMO PHARMACEUTICALS NV:

* ANNOUNCES GRANTING OF MARKETING AUTHORIZATION IN ITALY TO RIFAMYCIN SV MMX (STADMYCIN™) BY ITALIAN AIFA

* WILL RECEIVE A MILESTONE PAYMENT OF EUR 1.5M FROM E.G. DUE ON GRANT OF THIS MARKETING AUTHORIZATION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up